Predictive value of noninvasivelydetermined endothelial dysfunction for long-term cardiovascular events inpatients with peripheral vascular disease
暂无分享,去创建一个
Michael T. Watkins | M. Watkins | J. Menzoian | J. Keaney | Z. Nedeljkovic | N. Gokce | J. Vita | Noyan Gokce | Joseph A. Vita | John F. Keaney | Liza M. Hunter | Zoran S. Nedeljkovic | James O. Menzoian | L. Hunter
[1] Joseph Loscalzo,et al. Thrombosis and Hemorrhage , 2002 .
[2] A. Quyyumi,et al. Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.
[3] J. Keaney,et al. Endothelial function: a barometer for cardiovascular risk? , 2002, Circulation.
[4] M. Watkins,et al. Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function: A Prospective Study , 2002, Circulation.
[5] E. Benjamin,et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.
[6] T. Meinertz,et al. Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.
[7] F. Perticone,et al. Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients , 2001, Circulation.
[8] R. Karas,et al. Need for standardization of noninvasive assessment of vascular endothelial function. , 2001, American Heart Journal.
[9] K. Kostner,et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. , 2000, The American journal of cardiology.
[10] A M Zeiher,et al. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.
[11] S. Higano,et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.
[12] J. Keaney,et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1999, Circulation.
[13] F. Ohsuzu,et al. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. , 1998, The American journal of cardiology.
[14] M. Corretti,et al. Estrogens, progestins, and heart disease: can endothelial function divine the benefit? , 1998, Circulation.
[15] A. Yeung,et al. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. , 1996, The American journal of cardiology.
[16] G. Levine,et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.
[17] A. Yeung,et al. Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.
[18] P. Ganz,et al. Systemic nature of endothelial dysfunction in atherosclerosis. , 1995, The American journal of cardiology.
[19] J. Vane,et al. Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.
[20] E. Cook,et al. Correlation Between Preoperative Ischemia and Major Cardiac Events After Peripheral Vascular Surgery , 1989, The New England journal of medicine.